Related Experiment Video

Updated: Jan 27, 2026

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

20.2K

Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CON

Amanulla Khaji1, Colleen Hanley1, Peter R Kowey2

  • 1Lankenau Heart Institute, 100 East Lancaster Avenue, Wynnewood, PA 19087, USA.

Cardiology Clinics
|March 31, 2019
PubMed

Insights

Heart failure (HF) and atrial fibrillation (AF) frequently coexist, posing significant health challenges. This review suggests catheter ablation is not the primary treatment for AF in HF patients.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Heart failure (HF) and atrial fibrillation (AF) are prevalent cardiovascular conditions.
  • Their frequent coexistence significantly increases morbidity and mortality.
  • Managing patients with both HF and AF presents complex clinical challenges.

Purpose of the Study:

  • To review the current management strategies for atrial fibrillation (AF) in patients with heart failure (HF).
  • To provide evidence-based insights into the role of catheter ablation for AF in this specific patient population.

Main Methods:

  • Literature review of existing guidelines and clinical studies.
  • Analysis of treatment outcomes for AF in HF patients.

Main Results:

  • Pharmacologic therapy for HF is crucial.
  • There is no definitive consensus on the optimal treatment for AF in patients with concomitant HF.
  • Catheter ablation is not recommended as a first-line therapy for AF in HF patients.

Conclusions:

  • The management of AF in HF patients requires careful consideration of available therapeutic options.
  • Catheter ablation should be considered after other treatment modalities have been explored.
  • Further research is needed to establish clear guidelines for AF management in HF.

Keywords:
Atrial fibrillationCardiac resynchronization therapyCatheter ablationHeart failure with preserved ejection fractionHeart failure with reduced ejection fraction

More Related Videos

Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation04:58

Reduced Procedure Time and Variability with Active Esophageal Cooling During Radiofrequency Ablation for Atrial Fibrillation

Published on: August 25, 2022

2.5K
Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation06:25

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation

Published on: March 15, 2020

10.5K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
301
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
893